Parameters | HR (95% CI) | p-value |
Univariate Cox analysis | ||
Age | 1.016 (1.001–1.031) | 0.032 |
Male sex | 0.910 (0.685–1.209) | NS |
Smoking | 0.737 (0.568–0.956) | 0.021 |
PFT % pred | ||
FVC | 0.976 (0.968–0.984) | <0.001 |
DL,CO | 0.978 (0.971–0.986) | <0.001 |
TLC | 0.975 (0.965–0.984) | <0.001 |
BAL | ||
Macrophages | 1.003 (0.993–1.014) | NS |
Lymphocytes | 0.998 (0.985–1.012) | NS |
Neutrophils | 0.996 (0.980–1.012) | NS |
Eosinophils | 0.979 (0.941–1.018) | NS |
CRP | 1.073 (0.808–1.423) | NS |
Steroid with/without cytotoxic agent | 1.529 (1.177–1.986) | 0.001 |
Occurrence of AE# | 2.770 (2.132–3.599) | <0.001 |
Multivariate Cox analysis¶ | ||
Age | 1.017 (1.001–1.033) | 0.032 |
PFT % pred | ||
FVC | 0.987 (0.977–0.997) | 0.009 |
DL,CO | 0.985 (0.976–0.994) | 0.001 |
Steroid with/without cytotoxic agent | 1.552 (1.113–2.164) | 0.010 |
Occurrence of AE | 2.592 (1.888–3.560) | <0.001 |
HR: hazard ratio; PFT: pulmonary function test; % pred: % predicted; FVC: forced vital capacity; DL,CO: carbon monoxide diffusing capacity of the lung; TLC: total lung capacity; BAL: bronchoalveolar lavage; CRP: C-reactive protein; AE: acute exacerbation; NS: not significant. #: overall occurrence during follow up; ¶: TLC % pred was excluded from the multivariate analysis due to the close correlation between FVC and TLC % pred (r = 0.765; p<0.001).